CAS: 1803274-65-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | BAY-1436032 REF: AN-AG00AMHDCAS: 1803274-65-8 | ≥98% | 131,00 €~636,00 € | Mié 08 May 24 |
 | BAY-1436032 REF: TM-TQ0042CAS: 1803274-65-8 | 99.65% | A consultar | Mié 15 May 24 |
 | BAY-1436032 REF: 3D-DXC27465CAS: 1803274-65-8 | Min. 95% | A consultar | Jue 20 Jun 24 |
Ref: AN-AG00AMHD
| 1mg | 131,00 € | |
| 5mg | 319,00 € | |
| 10mg | 636,00 € |
Entrega estimada en Estados Unidos, el Miércoles 8 de Mayo de 2024
BAY-1436032
CAS:1803274-65-8
BAY-1436032 is a novel, selective and orally available inhibitor of pan-mutant isocitrate dehydrogenase 1 (IDH1).
Fórmula:
C26H30F3N3O3
Pureza:
99.65%
Forma y color:
Solid
Peso molecular:
489.53
Ref: TM-TQ0042
| 1mg | 37,00 € | |
| 5mg | 78,00 € | |
| 10mg | 118,00 € | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 1ml*10 (DMSO) | 83,00 € |
Entrega estimada en Estados Unidos, el Miércoles 15 de Mayo de 2024
BAY-1436032
CAS:1803274-65-8
BAY-1436032 is a novel small molecule inhibitor of CXCR4. It has been shown to be …
Fórmula:
C26H30F3N3O3
Pureza:
Min. 95%
Peso molecular:
489.53 g/mol
Ref: 3D-DXC27465
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
